Zobrazeno 1 - 10 of 393 pro vyhledávání: '"Jb, Andersen"'
3
[Polyglyconate or polyglycolic acid suture in patients with suspected impaired wound healing]
Autor: Palle Jörn Sloth Osther, Gjøde P, Bb, Mortensen, Pb, Mortensen, Jb, Andersen, Gottrup F
Publikováno v: Europe PubMed Central
A randomized study of abdominal fascial closure using interrupted polyglyconate and polyglycolic acid sutures after laparotomy was carried out in 204 consecutive patients with suspected impaired wound healing. There were no statistically significant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::383f81f2578af5752fb2025c406af4ac
https://pubmed.ncbi.nlm.nih.gov/9072856
Zobrazit plný text záznamu
4
Evidence of long distance airborne transmission of Aujeszky's disease (pseudorabies) virus
Autor: Ls, Christensen, Jan Mousing, Mortensen S, Kj, Soerensen, Sb, Strandbygaard, Ca, Henriksen, Jb, Andersen
Publikováno v: Europe PubMed Central
Aujeszky's disease has been the subject of an eradication campaign in Denmark since 1980. A detailed knowledge of the virus strains present in the country was provided by restriction fragment analyses of older clinical isolates, and of isolates from
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::30b0153cdcbc1ce00fc3d000b624dffb
http://europepmc.org/abstract/med/1980166
Zobrazit plný text záznamu
6
Akademický článek
The role of mesenchymal cells in cholangiocarcinoma.
Autor: Sueca-Comes M; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Rusu EC; Institute of Integrative Systems Biology (I2Sysbio), University of Valencia and CSIC, Spain., Ashworth JC; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK.; School of Veterinary Medicine and Science, Sutton Bonington Campus, Leicestershire, LE12 5RD, UK., Collier P; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Probert C; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Ritchie A; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Meakin M; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Mongan NP; School of Veterinary Medicine and Science, Sutton Bonington Campus, Leicestershire, LE12 5RD, UK.; Department of Pharmacology, Weill Cornell Medicine, 10065, NY, USA., Egbuniwe IU; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Andersen JB; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Bates DO; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK., Grabowska AM; Translational Medical Science, School of Medicine, Biodiscovery Institute, University of Nottingham, UK.
Publikováno v: Disease models & mechanisms [Dis Model Mech] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Zobrazit plný text záznamu
7
Akademický článek
Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian Tumors.
Autor: Oliveira DVNP; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Biskup E; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., O'Rourke CJ; Biotech Research & Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Hentze JL; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Andersen JB; Biotech Research & Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Høgdall C; Department of Gynecology, Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Høgdall EV; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark. estrid.hoegdall@regionh.dk.
Publikováno v: Molecular diagnosis & therapy [Mol Diagn Ther] 2024 Nov; Vol. 28 (6), pp. 821-834. Date of Electronic Publication: 2024 Oct 16.
Zobrazit plný text záznamu
8
Akademický článek
PARP-1 selectively impairs KRAS -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.
Autor: Keggenhoff FL; First Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Castven D; Department of Medicine I, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Becker D; First Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Stojkovic S; Department of Medicine I, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Castven J; Department of Medicine I, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Zimpel C; Department of Medicine I, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Straub BK; Institute of Pathology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; Tissue Biobank of the University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Gerber T; Institute of Pathology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Langer H; Cardiology Angiology, University Medical Centre, Mannheim, Germany., Hähnel P; Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Kindler T; Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Fahrer J; Department of Chemistry, RPTU Kaiserslautern-Landau, Kaiserslautern, Germany., O'Rourke CJ; Department of Health and Medical Sciences, University of Copenhagen Biotech Research & Innovation Centre, Kobenhavn, Denmark., Ehmer U; Department of Internal Medicine II, Klinikum rechts der Isar der Technischen Universitat, München, Germany., Saborowski A; Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany., Ma L; Laboratory of Human Carcinogenesis, National Cancer Institute, Center for Cancer Research, Bethesda, Maryland, USA., Wang XW; Laboratory of Human Carcinogenesis, National Cancer Institute, Center for Cancer Research, Bethesda, Maryland, USA.; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Gaiser T; Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Matter MS; Institute of Pathology, University Hospital Basel, Basel, Switzerland., Sina C; Institute of Nutritional Medicine, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Derer S; Institute of Nutritional Medicine, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Lee JS; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roessler S; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Kaina B; Department of Toxicology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Andersen JB; Department of Health and Medical Sciences, University of Copenhagen Biotech Research & Innovation Centre, Kobenhavn, Denmark., Galle PR; First Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Marquardt JU; Department of Medicine I, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany Jens.Marquardt@uksh.de.
Publikováno v: Gut [Gut] 2024 Sep 09; Vol. 73 (10), pp. 1712-1724. Date of Electronic Publication: 2024 Sep 09.
Zobrazit plný text záznamu
9
Akademický článek
Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis.
Autor: Ruiz-Blázquez P; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; CiberEHD, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain., Fernández-Fernández M; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; CiberEHD, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain., Pistorio V; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France., Martinez-Sanchez C; CiberEHD, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain., Costanzo M; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy; CEINGE-Biotecnologie Avanzate Franco Salvatore s.c.ar.l., Naples, Italy., Iruzubieta P; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Research Institute Marqués de Valdecilla (IDIVAL), Santander, Spain., Zhuravleva E; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; LEO Foundation Skin Immunology Research Center (SIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Cacho-Pujol J; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain., Ariño S; CiberEHD, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain., Del Castillo-Cruz A; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain., Núñez S; CiberEHD, Spain., Andersen JB; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Ruoppolo M; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy; CEINGE-Biotecnologie Avanzate Franco Salvatore s.c.ar.l., Naples, Italy., Crespo J; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Research Institute Marqués de Valdecilla (IDIVAL), Santander, Spain., García-Ruiz C; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; CiberEHD, Spain; IDIBAPS, Barcelona, Spain; USC Research Center for ALPD, Los Angeles, United States; Associated Unit IIBB-IMIM, Barcelona, Spain., Pavone LM; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy., Reinheckel T; Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany; German Cancer Consortium (DKTK), DKFZ Partner Site Freiburg, Germany; Center for Biological Signaling Studies BIOSS, University of Freiburg, Germany., Sancho-Bru P; CiberEHD, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain., Coll M; CiberEHD, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain; Medicine Department, Faculty of Medicine, University of Barcelona, Spain., Fernández-Checa JC; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; CiberEHD, Spain; IDIBAPS, Barcelona, Spain; USC Research Center for ALPD, Los Angeles, United States; Associated Unit IIBB-IMIM, Barcelona, Spain., Moles A; Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain; CiberEHD, Spain; IDIBAPS, Barcelona, Spain; Associated Unit IIBB-IMIM, Barcelona, Spain. Electronic address: ana.moles@iibb.csic.es.
Publikováno v: Molecular metabolism [Mol Metab] 2024 Sep; Vol. 87, pp. 101989. Date of Electronic Publication: 2024 Jul 15.
Zobrazit plný text záznamu
10
Akademický článek
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features.
Autor: Lori G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pastore M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Navari N; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Piombanti B; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Booijink R; Department of Biomaterial Science and Technology, University of Twente Enschede, The Netherlands., Rovida E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Tusa I; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Lewinska M; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Andersen JB; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Lottini T; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Arcangeli A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Taddei ML; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pranzini E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Mancini C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Anceschi C; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Madiai S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Sacco E; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy., Rota S; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy., Trapani A; Department of Pharmacy-Drug Sciences, University of Bari, Bari, Italy., Agrimi G; Department of Biosciences, Biotechnologies and Environment, University of Bari, Bari, Italy., Ramazzotti M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Ostano P; Cancer Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, Italy., Peraldo Neia C; Cancer Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, Italy., Parri M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Carli F; Institute of Clinical Physiology, National Research Council, CNR, Pisa, Italy., Sabatini S; Institute of Clinical Physiology, National Research Council, CNR, Pisa, Italy., Gastaldelli A; Institute of Clinical Physiology, National Research Council, CNR, Pisa, Italy., Marra F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Raggi C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2024 Aug 06; Vol. 6 (10), pp. 101182. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje